AAPL vs DHR: Which Is the Better Buy?
Side-by-side comparison of Apple Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Apple Inc. · Technology
$270.23
+68.0% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
AAPL has more upside to fair value
(+68.0%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AAPL |
DHR |
| Current Price |
$270.23 |
$174.04 |
| Fair Value Estimate |
$454.10 |
$197.01 |
| Upside to Fair Value |
+68.0%
|
+13.2%
|
| Market Cap |
$3,971.8B |
$123.2B |
| Forward P/E |
33.8x
|
33.4x
|
| EV / EBITDA |
26.3x
|
20.3x
|
| Price / Sales |
9.1x
|
5.0x
|
| Price / FCF |
32.2x
|
23.3x
|
| Revenue Growth YoY |
+15.7%
|
+3.7%
|
| Gross Margin |
47.3%
|
60.7%
|
| Operating Margin |
32.4%
|
21.0%
|
| Return on Equity |
159.9%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.1%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Apple Inc. is a leading technology company specializing in consumer electronics, software, and services. The business quality is high due to its durable competitive moats including brand strength, network effects, and switching costs, supported by consistent earnings growth and strong operational execution under CEO Tim Cook. The company reported robust revenue growth of 15.7% and earnings growth…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
AAPL |
DHR |
| Zone Low |
$340.58 |
$147.76 |
| Zone High |
$385.99 |
$167.46 |
| In Buy Zone? |
Yes
|
No
|